Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease
Status: Enrolling
Updated:  12/10/2014
Clinical Research Facility
mi
from
Rochester, NY
A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease
Status: Enrolling
Updated: 12/10/2014
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Comparison of Silicone and Porous Plate Ahmed Glaucoma Valves
Comparison of Silicone and Porous Plate Ahmed Glaucoma Valves
Status: Enrolling
Updated:  12/15/2014
University of Virginia
mi
from
Charlottesville, VA
Comparison of Silicone and Porous Plate Ahmed Glaucoma Valves
Comparison of Silicone and Porous Plate Ahmed Glaucoma Valves
Status: Enrolling
Updated: 12/15/2014
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Effects of Sildenafil on Choroidal Thickness in AMD
Effects of Sildenafil on Choroidal Thickness in Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/19/2014
Duke Eye Center
mi
from
Durham, NC
Effects of Sildenafil on Choroidal Thickness in AMD
Effects of Sildenafil on Choroidal Thickness in Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/19/2014
Duke Eye Center
mi
from
Durham, NC
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Birmingham, AL
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Beverly Hills, CA
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Glendale, CA
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
San Francisco, CA
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Golden, CO
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Golden, CO
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Fort Myers, FL
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Miami, FL
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Tamarac, FL
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Tamarac, FL
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Tampa, FL
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Atlanta, GA
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Chicago, IL
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Chicago, IL
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Ellsworth, ME
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Ellsworth, ME
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Baltimore, MD
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Baltimore, MD
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Boston, MA
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Cambridge, MA
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Cambridge, MA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Detroit, MI
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Royal Oak, MI
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
St. Louis, MO
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Palisades Park, NJ
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Palisades Park, NJ
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
New York, NY
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
New York, NY
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
New York, NY
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Belmont, NC
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Belmont, NC
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Durham, NC
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Winston-Salem, NC
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Dublin, OH
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Dublin, OH
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Portland, OR
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Arlington, TX
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Arlington, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Austin, TX
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Dallas, TX
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Houston, TX
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Houston, TX
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
McAllen, TX
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
McAllen, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
San Antonio, TX
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Temple, TX
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Temple, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Norfolk, VA
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Richmond, VA
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Morgantown, WV
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Morgantown, WV
Click here to add this to my saved trials
Lipoic Acid as a Treatment for Acute Optic Neuritis
Lipoic Acid as a Treatment for Acute Optic Neuritis: A Pilot Study
Status: Enrolling
Updated:  2/2/2015
Oregon Health and Science University
mi
from
Portland, OR
Lipoic Acid as a Treatment for Acute Optic Neuritis
Lipoic Acid as a Treatment for Acute Optic Neuritis: A Pilot Study
Status: Enrolling
Updated: 2/2/2015
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Functional Vision With ACRYSOF® IQ IOLs Blue Light Filtration
Functional Benefit With ACRYSOF® Natural Chromophore
Status: Enrolling
Updated:  2/3/2015
Alcon Call Center
mi
from
Fort Worth, TX
Functional Vision With ACRYSOF® IQ IOLs Blue Light Filtration
Functional Benefit With ACRYSOF® Natural Chromophore
Status: Enrolling
Updated: 2/3/2015
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Ozurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein Occlusion
Dexamethasone Implant With Rescue Ranibizumab for Treating Macular Edema Secondary to Retinal Vein Occlusion
Status: Enrolling
Updated:  2/19/2015
Wills Eye Retina Service
mi
from
Philadelphia, PA
Ozurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein Occlusion
Dexamethasone Implant With Rescue Ranibizumab for Treating Macular Edema Secondary to Retinal Vein Occlusion
Status: Enrolling
Updated: 2/19/2015
Wills Eye Retina Service
mi
from
Philadelphia, PA
Click here to add this to my saved trials